About: The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific journal article

Attributes	Values
rdf:type	Item
description	artículu científicu espublizáu en 2002 (ast) vědecký článek publikovaný v roce 2002 (cs) наукова стаття, опублікована в лютому 2002 (uk) 2002 թվականի փետրվարին հրատարակված գիտական հոդված (hy) 2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած (hyw) مقالة علمية (نشرت في فبراير 2002) (ar) vedecký článok (publikovaný 2002/02/01) (sk) wetenschappelijk artikel (gepubliceerd op 2002/02/01) (nl) article scientifique publié en 2002 (fr) im Februar 2002 veröffentlichter wissenschaftlicher Artikel (de) scientific journal article (en)
publication date	wds:Q28646695-14C3C450-4E3C-4992-B7C2-D19D968CCBA2
publication date	2002-02-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q28646695-8BEDF64B-DCB9-4CD8-84E7-3E04106254E1
language of work or name	English
author name string	wds:Q28646695-EF4A1FB9-8AB6-4648-A705-C9CAC4529A77 wds:Q28646695-F87E632E-FFBD-437E-8B1E-88CB20D74B25
author name string	D. Gail McCarver Ronald N. Hines
rdfs:label	The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms (en) The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms (nl) The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms (ast)
skos:prefLabel	The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms (en) The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms (nl) The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms (ast)
name	The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms (en) The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms (nl) The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms (ast)
title	wds:Q28646695-ACB2BA76-315D-4501-93BD-3C166E6C1944
title	The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms (en)
page(s)	wds:Q28646695-B572AF71-EFE5-4F1D-84C9-BB826DF12E5D
page(s)	361–366
instance of	wds:Q28646695-18e736f9-ea53-4081-b045-6c0146b9a6cb wds:Q28646695-9F731680-C919-4BCD-9072-7A192D0D097E
instance of	review article scholarly article
PubMed ID	wds:Q28646695-47E43B30-4E02-48EE-89C6-A2FF8F1AA50F
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11805192
PubMed ID	11805192
published in	wds:Q28646695-9B739A4C-7CCB-4668-AEC7-E00995DF00EE
published in	Journal of Pharmacology and Experimental Therapeutics
issue	wds:Q28646695-492702FD-985F-4A83-B7DA-6C64634F50A0
volume	wds:Q28646695-05D01FF4-504B-4800-921B-7356BB0F5D39
issue	2
volume	300
DOI	wds:Q28646695-86B6E7BC-E65F-4F53-B798-A37F0A1130BE
DOI	http://dx.doi.org/10.1124/JPET.300.2.361
DOI	10.1124/JPET.300.2.361
Fatcat ID	wds:Q28646695-C8F573A9-C8C6-4F29-ACB5-F587CE9589D1
Fatcat ID	release_2hjii4pturcabhvaxqiad4ddcm
ResearchGate publication ID	wds:Q28646695-40CC9A8E-A70A-4B84-AD63-4406D27C1EF4
ResearchGate publication ID	11554320
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q28646695
is cites work of	Self-similarity in NMR Spectra: An Application in Assessing the Level of Cysteine Maternal smoking during pregnancy, genetic polymorphisms of metabolic enzymes, and childhood acute leukemia: the ESCALE Study (SFCE) Inherited disorders of bilirubin clearance Fetal liver bisphenol A concentrations and biotransformation gene expression reveal variable exposure and altered capacity for metabolism in humans Gene expression profiling reveals a regulatory role for ROR alpha and ROR gamma in phase I and phase II metabolism Human milk biomonitoring data: interpretation and risk assessment issues A mechanistic approach for the scaling of clearance in children. Interferon-gamma plays protective roles in sodium arsenite-induced renal injury by up-regulating intrarenal multidrug resistance-associated protein 1 expression. Translating pharmacogenetics and pharmacogenomics into drug development for clinical pediatrics and beyond Prenatal and perinatal analgesic exposure and autism: an ecological link Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia Neonatal pharmacology: extensive interindividual variability despite limited size Incorporating pharmacokinetic differences between children and adults in assessing children's risks to environmental toxicants Mode of action: neurotoxicity induced by thyroid hormone disruption during development--hearing loss resulting from exposure to PHAHs Alterations in drug disposition during pregnancy: implications for drug therapy Population-based analysis of methadone distribution and metabolism using an age-dependent physiologically based pharmacokinetic model Role of CAR and PXR in xenobiotic sensing and metabolism Molecular mechanisms underlying chemical liver injury Developmental pharmacology: neonates are not just small adults... Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial Prenatal expression of N-acetyltransferases in C57Bl/6 mice A framework for assessing risks to children from exposure to environmental agents The epidemiology of hepatoblastoma Cancer risk among children with very low birth weights Cell-based models to study hepatic drug metabolism and enzyme induction in humans Hepatic function and physiology in the newborn Review on genetic variants and maternal smoking in the etiology of oral clefts and other birth defects Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system Pharmacokinetics and safety of montelukast oral granules in children 1 to 3 months of age with bronchiolitis Xenobiotic metabolism capacities of human skin in comparison with a 3D-epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: phase II enzymes Paediatric pharmacokinetics: key considerations Ontogeny of hepatic and renal systemic clearance pathways in infants: part I. Expression of the sulfotransferase 1C family: implications for xenobiotic toxicity Patterns of drug utilization in a neonatal intensive care unit Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease. Pharmacokinetics in the newborn Novel roles for AhR and ARNT in the regulation of alcohol dehydrogenases in human hepatic cells Phenotype prediction of nonsynonymous single nucleotide polymorphisms in human phase II drug/xenobiotic metabolizing enzymes: perspectives on molecular evolution Morphine glucuronidation in preterm neonates, infants and children younger than 3 years Pregnane X receptor and drug-induced liver injury. Microstructuring of multiwell plates for three-dimensional cell culture applications by ultrasonic embossing Bisphenol A-associated alterations in the expression and epigenetic regulation of genes encoding xenobiotic metabolizing enzymes in human fetal liver. Mechanisms of gender-specific regulation of mouse sulfotransferases (Sults). Clinical pharmacology in the adolescent oncology patient Influence of Matrigel-overlay on constitutive and inducible expression of nine genes encoding drug-metabolizing enzymes in primary human hepatocytes

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software